Form 4 for TECH Bio-Techne
Accepted 2022-10-31 00:00:00 ET · period of report 2022-10-27 · accession 0001415889-22-010912 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-31 | 2022-10-27 | TECH | Seth Alpna | Dir | A - Grant | $0.00 | +338 | 2,671 | +14% | $0 |
| D | 2022-10-31 | 2022-10-27 | TECH | Seth Alpna | Dir | A - Grant | $0.00 | +865 | 865 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-27 | A | A | 338 | $0.00 | 2,671 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2022-10-27 | A | A | 865 | $0.00 | 865 | D | $295.77 · — to 2032-10-27 | 865 Common Stock | (F1) The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders. |